Sponsor Pipeline

iOnctura Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06717126 A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal… Uveal Melanoma Active, Not Recruiting
Phase 1/2
NCT06887803 A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis… Myelofibrosis (MF) Recruiting
NCT06879717 A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without… Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Active, Not Recruiting
Phase 1
NCT04328844 A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers Solid Tumor, Adult Active, Not Recruiting
Disease Areas
Get alerts when iOnctura's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free